IP Library › Granted Patent US 7,393,662
Granted Patent B2
US 7,393,662 · App. 10/935,005 · Granted Jul 1, 2008

Human EPO mimetic hinge core mimetibodies, compositions, methods and uses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,393,662
App. No.
10/935,005
Granted
Jul 1, 2008
Kind
B2
Abstract

The present invention relates to at least one novel human EPO mimetic hinge core mimetibody or specified portion or variant, including isolated nucleic acids that encode at least one EPO mimetic hinge core mimetibody or specified portion or variant, EPO mimetic hinge core mimetibody or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.

Claims (4)

1. An erythropoietin mimetic hinge core mimetibody polypeptide, comprising SEQ ID NO: 88.

2. A composition comprising the erythropoietin hinge core mimetibody polypeptide according to claim 1 .

3. A composition according to claim 2 , wherein

said composition further comprises at least one pharmaceutically acceptable carrier or diluent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: CNA DEVELOPMENT LLC
To: CNA DEVELOPMENT GMBH
Reel/Frame 041060/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2009
From: CENTOCOR ORTHO BIOTECH INC. (FORMERLY KNOWN AS CENTOCOR, INC.)
To: CNA DEVELOPMENT LLC
Reel/Frame 023220/0197 →